Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
ACA, adjunct, adjunctive, Afimmune, Anchormark, Aspyrian, Austin, Auxilium, Behring, Bio, Biochemistry, Biocryst, biology, Branch, bridge, CEO, cerebrovascular, Charlotte, Chicago, Colby, College, Colorado, complement, Cowen, crossover, CSL, Dainippon, deadline, Dechert, Deed, deep, Diana, diplomate, diversifying, doctor, East, Eliksa, embolism, entirety, Eric, EVP, exact, exploratory, fantasy, feedback, Fellow, figure, forfeited, Galveston, gene, German, Gettysburg, globe, headcount, Hemotek, hyperoxygenation, ID, ILD, Immunome, infusion, instability, installment, Jolla, kidney, Kimmel, La, Lanchoney, Landlord, Lazard, learned, leverage, LLP, Loyola, mail, Main, McLean, mediation, Merck, middle, Militia, Mitochondrial, MitoCUREia, muscle, NaN, NC, neuropsychiatric, neuroscience, NuPathe, omicron, Omniox, ordinal, outset, PAD, Park, Pennsylvania, pharmacodynamic, Philadelphia, pioneering, PLC, point, pronounced, proven, Rakuten, recombinant, redirected, regenerative, remote, Ribonova, Roswell, roughly, RSU, running, sector, septic, simply, skeletal, spectrum, Spirovant, startup, subtracting, Suisse, Sumitomo, Sunstone, tailored, Topi, urology, variant, vasoconstrictor, vein, venture, Villanova, viral, VirTech, volunteer, walk, wave, wider, withheld
Removed:
adjuvant, air, ambulance, arm, augment, barrier, belief, bioavailable, capable, carryforward, cell, choosing, commenced, comparing, crossing, deadly, degeneration, discount, earning, efficiently, enrolling, ETASU, facing, feet, frequency, function, generation, hemorrhagic, incidence, inhibitor, ischemia, leased, liquid, location, macular, modified, month, neuronal, onset, orally, reaching, recoverable, remeasured, rental, rest, schedule, signal, son, square, survive, symptom, temozolomide, tPA, transport, undiscounted, unique, vessel, vivo, voluntarily, warranted
Filing tables
Filing exhibits
CRVO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-206408, No. 333-206409, No. 333-218060, No 333-226782, No. 333-233381, No. 333-238233, and No. 333-258760) on Form S-8, (No. 333-222203, No. 333-233686, No. 333-234234, No 333-235670, and No. 333-238818) on Form S-1, and (No. 333-218062, No. 333-222879, No. 333-231541, and No. 333-249057) on Form S-3 of our report dated March 18, 2022, with respect to the consolidated financial statements of Diffusion Pharmaceuticals Inc.
/s/ KPMG LLP
McLean, Virginia
March 18, 2022